Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardiovascular Syst (NQ: CSII )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cardiovascular Syst

< Previous 1 2 3 4 Next >
Cardiovascular Systems, Inc. Announces FDA 510(k) Submission of Innova Vascular, Inc.’s Thrombectomy System
From Cardiovascular Systems, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
Via Benzinga
Earnings Scheduled For February 3, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter. 
Via Benzinga
Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems: Q1 Earnings Insights
Cardiovascular Systems (NASDAQ:CSII) reported its Q1 earnings results on Thursday, November 3, 2022 at 06:05 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Cardiovascular Systems, Inc. Reports Fiscal 2023 First Quarter Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Announces Full Market Release of the 2.00 Max Crown for Peripheral Orbital Atherectomy Systems
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Host Earnings Conference Call on November 3, 2022
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Release Fiscal 2022 Fourth Quarter Results on August 2, 2022
From Cardiovascular Systems, Inc.
Via Business Wire
Why Needham Is Concerned About Competition Despite Promising Pipeline For This MedTech Stock
Needham believes the most meaningful announcements for Cardiovascular Systems Inc (NASDAQ: CSII) over the last 18 months could be: Partnership with Innova Vascular to develop a portfolio of... 
Via Benzinga
81 Biggest Movers From Yesterday
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares climbed 62.4% to close at $2.16 on Wednesday after gaining around 5% on Tuesday. 
Via Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Rail Vision Ltd. (NASDAQ: RVSN) shares jumped 51.7% to $2.0180 after gaining around 5% on Tuesday. Sharps Technology, Inc. (NASDAQ: STSS) rose 31.4% to $1.6815 after... 
Via Benzinga
Recap: Cardiovascular Systems Q3 Earnings
Cardiovascular Systems (NASDAQ:CSII) reported its Q3 earnings results on Wednesday, May 4, 2022 at 06:05 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Cardiovascular Systems, Inc. Reports Fiscal 2022 Third Quarter Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Host Earnings Conference Call on May 4, 2022
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare Conferences
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, Inc. Announces First In-Human Experience With Company’s Propel™ Percutaneous Ventricular Assist Device
From Cardiovascular Systems, Inc.
Via Business Wire
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
Biotech stocks aren't a sure thing, but one good sign is insiders buying up shares. These three all offer that enticing feature. 
Via InvestorPlace
Cardiovascular Systems, Inc. Announces Partnership With Innova Vascular, Inc. to Develop Full Line of Thrombectomy Devices
From Cardiovascular Systems, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on... 
Via Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers SOC Telemed (NASDAQ:TLMD) shares increased by 338.2% to $2.82 during Thursday's pre-market session. The market value of their outstanding shares is at $284.5... 
Via Benzinga
Cardiovascular Systems, Inc. Reports Fiscal 2022 Second Quarter Financial Results
From Cardiovascular Systems, Inc.
Via Business Wire
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
Cardiovascular Systems, Inc. to Participate at SVB Leerink 2022 Global Healthcare Conference
From Cardiovascular Systems, Inc.
Via Business Wire
Cardiovascular Systems, OrbusNeich Scores FDA Approval For Scoreflex Scoring Balloon
Cardiovascular Systems Inc (NASDAQ: CSII), along with OrbusNeich Medical Company Ltd, have received FDA PMA approval for OrbusNeich's Scoreflex NC... 
Via Benzinga
Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex® Scoring Balloon
From Cardiovascular Systems, Inc.
Via Business Wire
The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Corvus Says Chinese Angel Pharma Starts Phase 1/2 Blood Cancer Study Corvus... 
Via Benzinga
Cardiovascular Systems To Develop IVL Technology For Coronary, Peripheral Artery Diseases
Cardiovascular Systems Inc (NASDAQ: CSII) has announced the development of intravascular lithotripsy (IVL) technology for coronary and peripheral artery diseases. Enrolling... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.